Back to Results
First PageMeta Content
Clinical research / Food and Drug Administration / Pharmaceutical industry / Glucocorticoids / Betamethasone/calcipotriol / Betamethasone / Calcipotriol / Psoriasis / Clinical trial / Pharmaceutical sciences / Pharmacology / Medicine


N21-8152 S015 Calcipotriene and Cetamethasone Clinical PREA
Add to Reading List

Open Document

File Size: 3,69 MB

Share Result on Facebook

City

Reference / /

Company

LEO Pharma Inc. / Applicant Leo Pharmaceuticals Ltd / /

Continent

Europe / /

Country

United States / /

Event

FDA Phase / /

Facility

Laboratory Assessments / Laboratory Findings / /

IndustryTerm

Treatment of Psoriasis / study product / /

MedicalCondition

disease / headache / gastroenteritis / plaque psoriasis / tinea / least moderate psoriasis / Controlled Disease / lymphadenopathy / tension headache / Psoriasis / cough / pruritus / rash / Ointment Therapeutic Class Psoriasis / upper respiratory tract infection / /

Organization

FDA / Advisory Committee / MD NDA / /

Person

McCord Review / /

Position

Investigator / /

Product

Taclonex / Calcipotriene / betamethasone dipropionate / S-15 / Taclonex® / psoriasis / Taclonex ® Ointment / /

Technology

Pharmacokinetics / Pharmacodynamics / /

SocialTag